Danova M - Search Results

1

Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.

Ferrari S, Rovati B, Cucca L, Scarabelli C, Presti M, Beccaria C, Collovà E, Porta C, Danova M. Ferrari S, et al. Among authors: danova m. Oncol Rep. 2002 Sep-Oct;9(5):1107-13. Oncol Rep. 2002. PMID: 12168081

2

Anemia and epoetin alfa in high-dose chemotherapy programs for breast cancer patients.

Danova M, Ferrari S. Danova M, et al. Semin Oncol. 2002 Jun;29(3 Suppl 8):21-5. doi: 10.1053/sonc.2002.33529. Semin Oncol. 2002. PMID: 12082650 Review.

3

Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.

Ferrari S, Rovati B, Porta C, Alessandrino PE, Bertolini A, Collovà E, Riccardi A, Danova M. Ferrari S, et al. Among authors: danova m. Cancer Immunol Immunother. 2003 Jun;52(6):359-66. doi: 10.1007/s00262-002-0365-4. Epub 2003 Mar 27. Cancer Immunol Immunother. 2003. PMID: 12664135 Free PMC article.

4

Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.

Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M. Ferrari S, et al. Among authors: danova m. Oncol Rep. 2005 Jul;14(1):113-20. Oncol Rep. 2005. PMID: 15944777

5

Immunological stress in kidney cancer patients undergoing either open nephrectomy or nephron-sparing surgery: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.

Porta C, Bonomi L, Lillaz B, Klersy C, Imarisio I, Paglino C, Rovati B, Danova M, Ferraris E, Mensi M, Rovereto B. Porta C, et al. Among authors: danova m. Oncol Rep. 2008 Dec;20(6):1511-9. Oncol Rep. 2008. PMID: 19020735

6

[Topotecan: a new field of use].

Ferrari S, Danova M. Ferrari S, et al. Among authors: danova m. Tumori. 1999 Nov-Dec;85(6 Suppl 1):S23-8. Tumori. 1999. PMID: 10786197 Italian.

7

Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy: an echocardiographic study.

Balloni L, Porta C, Rossi S, Gola A, Pugliese P, Ferrari S, Bovio A, Danova M, Riccardi A. Balloni L, et al. Among authors: danova m. Oncol Rep. 2000 Jul-Aug;7(4):887-90. doi: 10.3892/or.7.4.887. Oncol Rep. 2000. PMID: 10854564 Clinical Trial.

8

Weekly taxanes in metastatic breast cancer (review).

Zimatore M, Danova M, Vassallo E, Porta C, Macaluso MC, Schittone L, Riccardi A, Palmeri S. Zimatore M, et al. Among authors: danova m. Oncol Rep. 2002 Sep-Oct;9(5):1047-52. Oncol Rep. 2002. PMID: 12168071 Review.

9

Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.

Porta C, Bonomi L, Lillaz B, Paglino C, Rovati B, Imarisio I, Morbini P, Villa C, Danova M, Mensi M, Rovereto B. Porta C, et al. Among authors: danova m. Anticancer Res. 2007 Jan-Feb;27(1A):165-73. Anticancer Res. 2007. PMID: 17352228 Free article.

10

In vivo biological effects of pegfilgrastim after myelosuppressive chemotherapy in breast cancer.

Danova M, Bencardino K, Manzoni M, Grasso D, Mariucci S, Rovati B. Danova M, et al. Anticancer Res. 2007 Sep-Oct;27(5A):3399-402. Anticancer Res. 2007. PMID: 17970086 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters